New drugs in the management of small cell lung cancer

Johnson, 1986, Small cell carcinoma of the lung, C.R.C. Crit. Rev. Oncol./Hematol., 4, 303, 10.1016/S1040-8428(86)80026-9 Joss, 1986, New drugs in small cell lung cancer, Cancer Treat. Rev., 13, 157, 10.1016/0305-7372(86)90003-4 Aisner, 1987, Identification of new drugs in small cell lung cancer: phase II agents first?, Cancer Treat. Rep., 71, 1131 Issell, 1985, Multicenter phase II trial of etoposide in refractory small cell lung cancer, Cancer Treat. Rep., 69, 127 Wolff, 1983, High dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung, Cancer Treat. Rep., 67, 957 Clark, 1988, Single agent etoposide in untreated extensive small cell lung cancer, Lung Cancer, 4, A108 Drings, 1987, Ifosfamide in the treatment of bronchial carcinoma, Contr. Oncol., 26, 294, 10.1159/000429551 Loehrer, 1986, Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group trial, Cancer Treat. Rep., 70, 919 Cantwell, 1986, Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer, Cancer Chemother. Pharmacol., 18, 529, 10.1007/BF00647447 Issell, 1982, Review, 7, 73 Creech, 1984, Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579), Cancer Treat. Rep., 68, 1183 Pedersen, 1984, Phase II study of teniposide in small cell carcinoma of the lung, Cancer Treat. Rep., 68, 1289 Woods, 1979, Treatment of small cell bronchogenic carcinoma with VM-26, Cancer Treat. Rep., 63, 211 Bork, 1986, Teniposide (VM-26), an overlooked highly active agent in small cell lung cancer, 4, 524 Schabel, 1979, cis-Dichlorodiamineplatinum (II), 63, 1459 Greco, 1979, Phase II studies in resistant small cell lung cancer, 20, 28 Evans, 1984, VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer, Cancer, 53, 1461, 10.1002/1097-0142(19840401)53:7<1461::AID-CNCR2820530706>3.0.CO;2-N Porter, 1985, Cisplatinum and VP-16-213 combination chemotherapy for refractory small cell carcinoma of the lung, Cancer Treat. Rep., 69, 479 Smith, 1985, Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer, Cancer Treat. Rep., 69, 43 Tamura, 1988, Phase II study of carboplatin in small cell lung cancer, Jpn. J. Clin. Oncol., 18, 27, 10.1093/jjco/18.1.27 Milroy, 1987, Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer, Cancer Chemother. Pharmacol., 20, 75, 10.1007/BF00252964 Cullen, 1987, Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease, Cancer Treat. Rep., 71, 1227 Malik, 1987, Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer, Cancer Treat. Rep., 71, 1291 Giaccone, 1987, 4′-Deoxydoxorubicin, an inactive drug in small cell lung cancer, Eur. J. Cancer Clin. Oncol., 23, 1407, 10.1016/0277-5379(87)90127-1 Kolaric, 1988, High dosage 4-epidoxorubicin in untreated patients with small cell lung cancer, 7, 212 Banham, 1988, Phase II study of high dose epirubicin in poor prognosis small cell lung cancer, 7, 217 Blackstein, 1989 Young, 1980, Vindesine trials at Memorial Sloan-Kettering Cancer Center, Cancer Treat. Rev., 7, 53, 10.1016/S0305-7372(80)80008-9 Morgan, 1983, Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer, 18, 172 Chang, 1984, Evaluation of vindesine in patients with refractory small cell cancer, Cancer Treat. Rep., 68, 1407 Postmus, 1987, Twice weekly vindesine, a phase II study in lung cancer, J. Cancer Res. Clin. Oncol., 113, 99, 10.1007/BF00389975 Osterlind, 1981, Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma, Cancer Treat. Rep., 65, 245 Osborne, R.J., Clark, P.I., Slevin, M.L. and Wrigley, P.F.M., High-dose cytarabine in small cell lung cancer. Cancer Treat. Rep., 71: 417–418. Stuart-Harris, 1986, Cytarabine: an inactive drug for extensive-stage small cell lung cancer, Cancer Treat. Rep., 70, 303 Chiuten, 1984, High dose Ara-C given as a continuous infusion or intermitent schedule in lung cancer, 3, 227 McHale, 1986, Evaluation of mitomycin in small cell lung carcinoma, Cancer Treat. Rep., 70, 675 Havsteen, 1981, 5-Fluorouracil in the treatment of small cell anaplastic carcinoma of the lung: a phase II trial, Cancer Treat. Rep., 65, 123 Sorensen, 1983, Phase II study of vinblastine in small cell carcinoma of the lung, Cancer Treat. Rep., 67, 293 Pedersen, 1982, Phase II study of procarbazine in small cell carcinoma of the lung, Cancer Treat. Rep., 66, 273 Myers, 1984, Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer, Cancer Treat. Rep., 68, 927 Goldsweig, 1982, Hexamethylmelamine as a single agent in the treatment of small cell carcinoma of the lung, Am. J. Clin. Oncol., 5, 267, 10.1097/00000421-198206000-00005 Madajewicz, S., Takita, H. and Creaven, P.J., Phase II study of iproplatin in small cell carcinoma of the lung. Proc. Am. Soc. Clin. Oncol., 3: 224. Cunningham, D., Banham, S.W. and Soukop, M., Small cell lung cancer: results of a phase II study of 1,2,4 triglycidylurazol. Cancer Chemother. Pharmacol., 17: 85–86. Floridi, 1981, Effects of lonidamine on the energy metabolism of Ehrlich ascites tumor cells, Cancer Res., 41, 4661 Murray, N., Shah, A. and Band, P., Phase II study of lonidamine in patients with small cell carcinoma of the lung. Cancer Treat. Rep., 71: 1283–1284. Mattson, 1988, Low-dose α-interferon as maintenance therapy for patients with small cell lung cancer, 4, A173 Doyle, 1985, Markedly decreased expression class I histocompatibility antigens, protein, and mRNA in human cell lung cancer, J. Exp. Med., 161, 1135, 10.1084/jem.161.5.1135 Simon, 1985, Design and conduct of clinical trials, 329 Cohen, 1985, Phase II studies in small cell lung cancer: an analysis of 97 trials, 4, 190 Roed, 1987, In vitro evaluation of a new nitrosurea, TCNU, against human small cell lung cancer cell lines, Cancer Chemother. Pharmacol., 19, 315, 10.1007/BF00261480 Roed, 1988, The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay, Eur. J. Cancer Clin. Oncol., 24, 247, 10.1016/0277-5379(88)90261-1